Ikarian Capital, LLC’s Rapt Therapeutics Inc Position
Does Ikarian Capital, LLC own Rapt Therapeutics Inc (RAPT)? Not currently — the last reported position was 665.3K shares worth $23M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$23M
Q4 2025
Shares
665.3K
% of Portfolio
+1.76%
Quarters Held
2
position exited
Position History RAPT
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ikarian Capital, LLC’s full portfolio or all institutional holders of RAPT.